Abstract
Cystic lung disease (CLD) is a group of lung disorders characterized by the presence of multiple cysts, defined as air-filled lucencies or low-attenuating areas, bordered by a thin wall (usually < 2 mm). The recognition of CLDs has increased with the widespread use of computed tomography. This article addresses the mechanisms of cyst formation and the diagnostic approaches to CLDs. A number of assessment methods that can be used to confirm CLDs are discussed, including high-resolution computed tomography, pathologic approaches, and genetic/ serologic markers, together with treatment modalities, including new therapeutic drugs currently being evaluated. The CLDs covered by this review are lymphangioleiomyomatosis, pulmonary Langerhans cell histiocytosis, Birt-Hogg-Dube syndrome, lymphocytic interstitial pneumonia/follicular bronchiolitis, and amyloidosis.
Original language | English |
---|---|
Pages (from-to) | 229-238 |
Number of pages | 10 |
Journal | Korean Journal of Internal Medicine |
Volume | 32 |
Issue number | 2 |
DOIs | |
Publication status | Published - 2017 |
Externally published | Yes |
Keywords
- Birt-Hogg-Dube syndrome
- Cystic lung disease
- Histiocytosis
- Lang-erhans-cell
- Lymphangioleiomyomatosis
ASJC Scopus subject areas
- Internal Medicine